A Chlamydia effector combining deubiquitination and acetylation activities induces Golgi fragmentation. (December 2018)

• Record Type: Journal Article
• Authors: Pruneda, Jonathan; Bastidas, Robert; Bertsoulaki, Erithelgi; Swatek, Kirby; Santhanam, Balaji; Clague, Michael; Valdivia, Raphael; Urbé, Sylvie; Komander, David
• Is Part Of: Nature microbiology. Volume 3:Number 12(2018)
• Page Start: 1377
• Page End: 1384
• Publication Date: 2018-12
• Subjects: Microbiology -- Periodicals; 579.05
• DOI: 10.1038/s41564-018-0271-y
• Languages: English
• ISSNs: 2058-5276

Abstract

Abstract Pathogenic bacteria are armed with potent effector proteins that subvert host signalling processes during infection1 . The activities of bacterial effectors and their associated roles within the host cell are often poorly understood, particularly forChlamydia trachomatis 2, a World Health Organization designated neglected disease pathogen. We identify and explain remarkable dual Lys63-deubiquitinase (DUB) and Lys-acetyltransferase activities in theChlamydia effector ChlaDUB1. Crystal structures capturing intermediate stages of each reaction reveal how the same catalytic centre of ChlaDUB1 can facilitate such distinct processes, and enable the generation of mutations that uncouple the two activities. TargetedChlamydia mutant strains allow us to link the DUB activity of ChlaDUB1 and the related, dedicated DUB ChlaDUB2 to fragmentation of the host Golgi apparatus, a key process inChlamydia infection for which effectors have remained elusive. Our work illustrates the incredible versatility of bacterial effector proteins, and provides important insights towards understandingChlamydia pathogenesis. Chlamydia trachomatis DUB1 uses a single catalytic centre to carry out dual lysine deubiquitinase and acetyltransferase activity. Deubiquitination is required for Golgi fragmentation during bacterial infection.